Post-transcriptional (re)programming of B lymphocyte development: From bench to bedside?
- PMID: 38763703
- PMCID: PMC12320199
- DOI: 10.1016/bs.ai.2024.03.003
Post-transcriptional (re)programming of B lymphocyte development: From bench to bedside?
Abstract
Hematopoiesis, a process which generates blood and immune cells, changes significantly during mammalian development. Definitive hematopoiesis is marked by the emergence of long-term hematopoietic stem cells (HSCs). Here, we will focus on the post-transcriptional differences between fetal liver (FL) and adult bone marrow (ABM) HSCs. It remains unclear how or why exactly FL HSCs transition to ABM HSCs, but we aim to leverage their differences to revive an old idea: in utero HSC transplantation. Unexpectedly, the expression of certain RNA-binding proteins (RBPs) play an important role in HSC specification, and can be employed to convert or reprogram adult HSCs back to a fetal-like state. Among other features, FL HSCs have a broad differentiation capacity that includes the ability to regenerate both conventional B and T cells, as well as innate-like or unconventional lymphocytes such as B-1a and marginal zone B (MzB) cells. This chapter will focus on RNA binding proteins, namely LIN28B and IGF2BP3, that are expressed during fetal life and how they promote B-1a cell development. Furthermore, this chapter considers a potential clinical application of synthetic co-expression of LIN28B and IGF2BP3 in HSCs.
Keywords: B lymphocyte development; Fetal hematopoiesis; Hematopoietic stem cells; In utero transplantation; Innate-like lymphocytes; MicroRNA; Post-transcriptional regulation; RNA-binding protein.
Copyright © 2024. Published by Elsevier Inc.
Figures
References
-
- Alejo-Valle O, Weigert K, Bhayadia R, Ng M, Issa H, Beyer C, Emmrich S, Schuschel K, Ihling C, Sinz A, Zimmermann M, Wickenhauser C, Flasinski M, Regenyi E, Labuhn M, Reinhardt D, Yaspo ML, Heckl D, & Klusmann JH (2022). The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis. Blood, 139(5), 651–665. 10.1182/blood.2021012231 - DOI - PMC - PubMed
-
- Amabile G, Welner RS, Nombela-Arrieta C, D’Alise AM, Di Ruscio A, Ebralidze AK, Kraytsberg Y, Ye M, Kocher O, Neuberg DS, Khrapko K, Silberstein LE, & Tenen DG (2013). In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood, 121(8), 1255–1264. 10.1182/blood-2012-06-434407 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
